Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate UpdateApril 16, 2025
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive OfficerMarch 20, 2025
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq RulesMarch 3, 2025
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceFebruary 19, 2025
